Recombinant anti-human-Amyloid Beta Antibody (Lecanemab Biosimilar)

Product code: 12-9407

Clonality : Monoclonal
Application : Functional Assay, ELISA, ICC/IF, FACS
Reactivity : Human

Shipping Info:

Order now and get it on Tuesday December 24, 2024

Write a review for this product on BioCompare
Get $20 gift card from Amazon
Size
Price
50 μg
$400.00 

Add to Wish List

Shipping Info:

Order now and get it on Tuesday December 24, 2024

Same day delivery FREE on San Diego area orders placed by 1.00 PM


Format : Purified
Amount : 50 μg
Isotype : human IgG1
Purification : Purified from cell culture supernatant by affinity chromatography
Content : Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization.Sterile
Storage condition : Store at -20°C. Avoid repeated freeze and thaw cycles.
Gene : Amyloid
Gene ID : HGNC:620
Uniprot ID : P05067
Alternative Name : Amyloid beta, Lecanemab

Target: Amyloid Beta
Generic name: Lecanemab 
Product Origin: Recombinant in Human cells

People with Alzheimer’s disease have a protein called amyloid that continuously builds up in the brain. It starts with small forms of amyloid protein. These may clump together into larger forms, which can damage the brain cells. As they continue to build up, they can form harmful amyloid brain plaques. Lecanemab is humanized monoclonal antibodies targeting cerebral amyloid-beta (Aβ) plaques. 

References:

1. Panza F, Lozupone M, Logroscino G, Imbimbo BP. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2019;15(2):73–88..
 
 
 

Specificity: Human Amyloid beta. 

Inquire for more than 1 mg quantities.
 

 

For Research Use Only. Not for use in diagnostic/therapeutics procedures.

There are currently no product reviews

Customers who purchased this product also purchased

Most viewed Products